🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.

After moments of joining one community, a vendor posted contact information, where the majority of transactions occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Product Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.